{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T20:29:43Z","timestamp":1776544183891,"version":"3.51.2"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,1,10]],"date-time":"2010-01-10T00:00:00Z","timestamp":1263081600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1186\/1471-230x-10-1","type":"journal-article","created":{"date-parts":[[2010,1,13]],"date-time":"2010-01-13T06:39:19Z","timestamp":1263364759000},"source":"Crossref","is-referenced-by-count":67,"title":["How do patients with inflammatory bowel disease want their biological therapy administered?"],"prefix":"10.1186","volume":"10","author":[{"given":"Patrick B","family":"Allen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah","family":"Lindsay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tony CK","family":"Tham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,1,10]]},"reference":[{"issue":"9613","key":"392_CR1","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/S0140-6736(08)60304-9","volume":"371","author":"G D'Haens","year":"2008","unstructured":"D'Haens G, Baert F, van Assche G, Caenepeel P, Vergauwe P, Tuynman H, De Vos M, van Deventer S, Stitt L, Donner A, et al: Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial. Lancet. 2008, 371 (9613): 660-667. 10.1016\/S0140-6736(08)60304-9.","journal-title":"Lancet"},{"issue":"4","key":"392_CR2","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1053\/j.gastro.2009.06.061","volume":"137","author":"WJ Sandborn","year":"2009","unstructured":"Sandborn WJ, Rutgeerts P, Feagan BG, Reinisch W, Olson A, Johanns J, Lu J, Horgan K, Rachmilewitz D, Hanauer SB, et al: Colectomy Rate Comparison After Treatment of Ulcerative Colitis With Placebo or Infliximab. Gastroenterology. 2009, 137 (4): 1250-60. 10.1053\/j.gastro.2009.06.061.","journal-title":"Gastroenterology"},{"issue":"2","key":"392_CR3","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1053\/j.gastro.2008.10.051","volume":"136","author":"M Regueiro","year":"2009","unstructured":"Regueiro M, Schraut W, Baidoo L, Kip KE, Sepulveda AR, Pesci M, Harrison J, Plevy SE: Infliximab prevents Crohn's disease recurrence after ileal resection. Gastroenterology. 2009, 136 (2): 441-450. 10.1053\/j.gastro.2008.10.051. e441; quiz 716","journal-title":"Gastroenterology"},{"issue":"1","key":"392_CR4","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1053\/j.gastro.2006.11.041","volume":"132","author":"JF Colombel","year":"2007","unstructured":"Colombel JF, Sandborn WJ, Rutgeerts P, Enns R, Hanauer SB, Panaccione R, Schreiber S, Byczkowski D, Li J, Kent JD, et al: Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial. Gastroenterology. 2007, 132 (1): 52-65. 10.1053\/j.gastro.2006.11.041.","journal-title":"Gastroenterology"},{"issue":"5","key":"392_CR5","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1053\/j.gastro.2008.07.069","volume":"135","author":"BG Feagan","year":"2008","unstructured":"Feagan BG, Panaccione R, Sandborn WJ, D'Haens GR, Schreiber S, Rutgeerts PJ, Loftus EV, Lomax KG, Yu AP, Wu EQ, et al: Effects of adalimumab therapy on incidence of hospitalization and surgery in Crohn's disease: results from the CHARM study. Gastroenterology. 2008, 135 (5): 1493-1499. 10.1053\/j.gastro.2008.07.069.","journal-title":"Gastroenterology"},{"issue":"12","key":"392_CR6","doi-asserted-by":"publisher","first-page":"3132","DOI":"10.1111\/j.1572-0241.2008.02175.x","volume":"103","author":"EV Loftus","year":"2008","unstructured":"Loftus EV, Feagan BG, Colombel JF, Rubin DT, Wu EQ, Yu AP, Pollack PF, Chao J, Mulani P: Effects of adalimumab maintenance therapy on health-related quality of life of patients with Crohn's disease: patient-reported outcomes of the CHARM trial. Am J Gastroenterol. 2008, 103 (12): 3132-3141. 10.1111\/j.1572-0241.2008.02175.x.","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"392_CR7","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1177\/135581969700200209","volume":"2","author":"A Coulter","year":"1997","unstructured":"Coulter A: Partnerships with patients: the pros and cons of shared clinical decision-making. J Health Serv Res Policy. 1997, 2 (2): 112-121.","journal-title":"J Health Serv Res Policy"},{"issue":"7179","key":"392_CR8","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1136\/bmj.318.7179.318","volume":"318","author":"A Coulter","year":"1999","unstructured":"Coulter A, Entwistle V, Gilbert D: Sharing decisions with patients: is the information good enough?. BMJ. 1999, 318 (7179): 318-322.","journal-title":"BMJ"},{"key":"392_CR9","volume-title":"The expert patient: a new approach to chronic disease management for the 21st century","author":"Department of Health","year":"2001","unstructured":"Department of Health: The expert patient: a new approach to chronic disease management for the 21st century. 2001, Department of Health, 25216:"},{"issue":"5","key":"392_CR10","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/S0025-7125(03)00066-X","volume":"87","author":"C Teutsch","year":"2003","unstructured":"Teutsch C: Patient-doctor communication. Med Clin North Am. 2003, 87 (5): 1115-1145. 10.1016\/S0025-7125(03)00066-X.","journal-title":"Med Clin North Am"},{"key":"392_CR11","volume-title":"Health Affairs","author":"J Hibbard","year":"2004","unstructured":"Hibbard J: Moving toward a more patient-centred health care delivery system. Health Affairs. 2004, VAR 133-VAR135((Suppl Web Exclusive))"},{"issue":"6","key":"392_CR12","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1111\/j.1525-1497.2005.04101.x","volume":"20","author":"W Levinson","year":"2005","unstructured":"Levinson W, Kao A, Kuby A, Thisted RA: Not all patients want to participate in decision making. A national study of public preferences. J Gen Intern Med. 2005, 20 (6): 531-535. 10.1111\/j.1525-1497.2005.04101.x.","journal-title":"J Gen Intern Med"},{"issue":"4","key":"392_CR13","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/S0149-2918(02)85131-1","volume":"24","author":"JC Cappelleri","year":"2002","unstructured":"Cappelleri JC, Cefalu WT, Rosenstock J, Kourides IA, Gerber RA: Treatment satisfaction in type 2 diabetes: a comparison between an inhaled insulin regimen and a subcutaneous insulin regimen. Clin Ther. 2002, 24 (4): 552-564. 10.1016\/S0149-2918(02)85131-1.","journal-title":"Clin Ther"},{"issue":"5","key":"392_CR14","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1185\/030079902125000831","volume":"18","author":"M Johnson","year":"2002","unstructured":"Johnson M, Guilford S, Libretto SE: Patients have treatment preferences: a multicentre, double-blind, crossover study comparing rabeprazole and omeprazole. Curr Med Res Opin. 2002, 18 (5): 303-310. 10.1185\/030079902125000831.","journal-title":"Curr Med Res Opin"},{"issue":"12","key":"392_CR15","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1185\/030079905X74862","volume":"21","author":"R Emkey","year":"2005","unstructured":"Emkey R, Koltun W, Beusterien K, Seidman L, Kivitz A, Devas V, Masanauskaite D: Patient preference for once-monthly ibandronate versus once-weekly alendronate in a randomized, open-label, cross-over trial, the Boniva Alendronate Trial in Osteoporosis (BALTO). Curr Med Res Opin. 2005, 21 (12): 1895-1903. 10.1185\/030079905X74862.","journal-title":"Curr Med Res Opin"},{"issue":"11","key":"392_CR16","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1016\/S0149-2918(02)80085-6","volume":"24","author":"JA Simon","year":"2002","unstructured":"Simon JA, Lewiecki EM, Smith ME, Petruschke RA, Wang L, Palmisano JJ: Patient preference for once-weekly alendronate 70 mg versus once-daily alendronate 10 mg: a multicenter, randomized, open-label, crossover study. Clin Ther. 2002, 24 (11): 1871-1886. 10.1016\/S0149-2918(02)80085-6.","journal-title":"Clin Ther"},{"issue":"3","key":"392_CR17","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.maturitas.2003.12.012","volume":"48","author":"D Kendler","year":"2004","unstructured":"Kendler D, Kung AW, Fuleihan Gel H, Gonzalez Gonzalez JG, Gaines KA, Verbruggen N, Melton ME: Patients with osteoporosis prefer once weekly to once daily dosing with alendronate. Maturitas. 2004, 48 (3): 243-251. 10.1016\/j.maturitas.2003.12.012.","journal-title":"Maturitas"},{"issue":"2","key":"392_CR18","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/BF03324587","volume":"17","author":"M Weiss","year":"2005","unstructured":"Weiss M, Vered I, Foldes AJ, Cohen YC, Shamir-Elron Y, Ish-Shalom S: Treatment preference and tolerability with alendronate once weekly over a 3-month period: an Israeli multi-center study. Aging Clin Exp Res. 2005, 17 (2): 143-149.","journal-title":"Aging Clin Exp Res"},{"issue":"3","key":"392_CR19","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.1369-7625.2007.00440.x","volume":"10","author":"TW Weiss","year":"2007","unstructured":"Weiss TW, McHorney CA: Osteoporosis medication profile preference: results from the PREFER-US study. Health Expect. 2007, 10 (3): 211-223. 10.1111\/j.1369-7625.2007.00440.x.","journal-title":"Health Expect"},{"issue":"12","key":"392_CR20","doi-asserted-by":"publisher","first-page":"3139","DOI":"10.1111\/j.1572-0241.2002.07111.x","volume":"97","author":"K Olden","year":"2002","unstructured":"Olden K, DeGarmo RG, Jhingran P, Bagby B, Decker C, Markowitz M, Carter E, Bobbitt W, Dahdul A, DeCastro E, et al: Patient satisfaction with alosetron for the treatment of women with diarrhea-predominant irritable bowel syndrome. Am J Gastroenterol. 2002, 97 (12): 3139-3146. 10.1111\/j.1572-0241.2002.07111.x.","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"392_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/msc.110","volume":"6","author":"F Chilton","year":"2008","unstructured":"Chilton F, Collett RA: Treatment choices, preferences and decision-making by patients with rheumatoid arthritis. Musculoskeletal Care. 2008, 6 (1): 1-14. 10.1002\/msc.110.","journal-title":"Musculoskeletal Care"},{"issue":"12","key":"392_CR22","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1093\/rheumatology\/kel369","volume":"45","author":"EL Williams","year":"2006","unstructured":"Williams EL, Edwards CJ: Patient preferences in choosing anti-TNF therapies-R1. Rheumatology (Oxford). 2006, 45 (12): 1575-1576. 10.1093\/rheumatology\/kel369.","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"392_CR23","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1111\/j.1365-2036.2008.03902.x","volume":"29","author":"A Oussalah","year":"2009","unstructured":"Oussalah A, Babouri A, Chevaux J-B, Stancu L, Trouilloud I, Bensenane M, Boucekkine T, Bigard M-A, Peyrin-Biroulet L: Adalimumab for Crohn's disease with intolerance or lost response to infliximab: a 3-year single-centre experience. Alimentary Pharmacology & Therapeutics. 2009, 29 (4): 416-423. 10.1111\/j.1365-2036.2008.03902.x.","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"1","key":"392_CR24","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1097\/00004836-199201000-00005","volume":"14","author":"JR Love","year":"1992","unstructured":"Love JR, Irvine EJ, Fedorak RN: Quality of life in inflammatory bowel disease. J Clin Gastroenterol. 1992, 14 (1): 15-19. 10.1097\/00004836-199201000-00005.","journal-title":"J Clin Gastroenterol"},{"issue":"3","key":"392_CR25","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/0016-5085(89)90905-0","volume":"96","author":"G Guyatt","year":"1989","unstructured":"Guyatt G, Mitchell A, Irvine EJ, Singer J, Williams N, Goodacre R, Tompkins C: A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology. 1989, 96 (3): 804-810.","journal-title":"Gastroenterology"},{"issue":"1","key":"392_CR26","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/j.1572-0241.2007.01561.x","volume":"103","author":"AN Ananthakrishnan","year":"2008","unstructured":"Ananthakrishnan AN, Weber LR, Knox JF, Skaros S, Emmons J, Lundeen S, Issa M, Otterson MF, Binion DG: Permanent work disability in Crohn's disease. Am J Gastroenterol. 2008, 103 (1): 154-161. 10.1111\/j.1572-0241.2008.02054.x.","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"392_CR27","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/BF02600052","volume":"11","author":"RB Deber","year":"1996","unstructured":"Deber RB: Shared decision making in the real world. J Gen Intern Med. 1996, 11 (6): 377-378. 10.1007\/BF02600052.","journal-title":"J Gen Intern Med"},{"issue":"3","key":"392_CR28","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/j.1365-2036.2009.04033.x","volume":"30","author":"K Bodger","year":"2009","unstructured":"Bodger K, Kikuchi T, Hughes D: Cost-effectiveness of biological therapy for Crohn's disease: Markov cohort analyses incorporating United Kingdom patient-level cost data. Aliment Pharmacol Ther. 2009, 30 (3): 265-274. 10.1111\/j.1365-2036.2009.04033.x.","journal-title":"Aliment Pharmacol Ther"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-230X-10-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-10-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-10-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-10-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T08:01:07Z","timestamp":1548230467000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/1471-230X-10-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1,10]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["392"],"URL":"https:\/\/doi.org\/10.1186\/1471-230x-10-1","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,1,10]]},"article-number":"1"}}